Literature DB >> 29569429

Recommended composition of influenza virus vaccines for use in the 2018–2019 northern hemisphere influenza season.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29569429

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  8 in total

1.  Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.

Authors:  Brendan Flannery; Rebecca J Garten Kondor; Jessie R Chung; Manjusha Gaglani; Michael Reis; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Sara S Kim; Lenee Blanton; Krista Kniss; Alicia P Budd; Lynnette Brammer; Thomas J Stark; John R Barnes; David E Wentworth; Alicia M Fry; Manish Patel
Journal:  J Infect Dis       Date:  2020-01-01       Impact factor: 5.226

2.  Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine.

Authors:  Rebecca Garten; Lenee Blanton; Anwar Isa Abd Elal; Noreen Alabi; John Barnes; Matthew Biggerstaff; Lynnette Brammer; Alicia P Budd; Erin Burns; Charisse N Cummings; Todd Davis; Shikha Garg; Larisa Gubareva; Yunho Jang; Krista Kniss; Natalie Kramer; Stephen Lindstrom; Desiree Mustaquim; Alissa O'Halloran; Wendy Sessions; Calli Taylor; Xiyan Xu; Vivien G Dugan; Alicia M Fry; David E Wentworth; Jacqueline Katz; Daniel Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-06-08       Impact factor: 17.586

3.  Epidemiology and Genetic Variability of Circulating Influenza B Viruses in Uruguay, 2012-2019.

Authors:  María José Rivas; Miguel Alegretti; Leticia Cóppola; Viviana Ramas; Héctor Chiparelli; Natalia Goñi
Journal:  Microorganisms       Date:  2020-04-19

Review 4.  Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.

Authors:  Ian G Barr; Ruben O Donis; Jacqueline M Katz; John W McCauley; Takato Odagiri; Heidi Trusheim; Theodore F Tsai; David E Wentworth
Journal:  NPJ Vaccines       Date:  2018-10-09       Impact factor: 7.344

5.  Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season.

Authors:  N S Korsun; S G Angelova; I T Trifonova; I L Georgieva; I S Tzotcheva; S D Mileva; S E Voleva; A M Kurchatova; P I Perenovska
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.

Authors:  Patricia A Jorquera; Vasiliy P Mishin; Anton Chesnokov; Ha T Nguyen; Brian Mann; Rebecca Garten; John Barnes; Erin Hodges; Juan De La Cruz; Xiyan Xu; Jackie Katz; David E Wentworth; Larisa V Gubareva
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

7.  Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities.

Authors:  Aline da Rocha Matos; Katharina Wunderlich; Sebastian Schloer; Klaus Schughart; Robert Geffers; Martine Seders; Marlous de Witt; Anmari Christersson; Rainer Wiewrodt; Karsten Wiebe; Peter Barth; Andreas Hocke; Stefan Hippenstiel; Katja Hönzke; Ulf Dittmer; Kathrin Sutter; Ursula Rescher; Svetlana Rodionycheva; Nicoletta Matera; Stephan Ludwig; Linda Brunotte
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

8.  H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin Protein.

Authors:  Huihui Kong; Shufang Fan; Kosuke Takada; Masaki Imai; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  mBio       Date:  2021-12-07       Impact factor: 7.867
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.